FDA Inspection 1240689 — Karamjeet S. Sandhu, M.D.
The FDA completed an inspection of Karamjeet S. Sandhu, M.D. on Apr 30, 2024 in Duarte, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 30, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Duarte, CA (United States)
Additional Details
Clinical Investigator (CI)